A major outbreak of meningitis B linked to a nightclub in Kent has reignited debate over the UK's vaccination programme. Two young people have died and more are seriously ill after contracting the disease, which is believed to have originated at Club Chemistry in Canterbury in early March. Health authorities have launched a large-scale response, offering antibiotics to 30,000 people and meningitis B vaccines to up to 5,000 University of Kent students.
Health Secretary Wes Streeting has urged calm, stating that the risk of transmission is low and advising against seeking private vaccinations. However, demand for jabs has surged, leading to a national shortage. High street pharmacies Boots and Superdrug report a major spike in bookings, with some locations running out of stock.
Professor Andrew Preston, an expert in microbial pathogenicity at the University of Bath, described the outbreak as the largest cluster of cases in a generation, likely the result of a super-spreading event. He noted that meningitis can be difficult to detect, as symptoms often start mildly but can deteriorate rapidly. 'It can strike people we don't expect to die from an infectious disease, like university students,' he said.
Despite the outbreak, Preston emphasised that meningitis remains rare in the UK. The bacteria are typically spread through close and prolonged contact, such as kissing or sharing drinks. The UK has a highly effective vaccination programme for many strains, including meningitis A, C, W and Y, which has significantly reduced infection rates. However, meningitis B is not currently part of the routine adolescent vaccination schedule, prompting calls for its inclusion.
